Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction : Journal of Cardiovascular Pharmacology

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Drugs in the Pipeline: Original Article

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W. PharmD*; Wohlford, George F. PharmD*; Del Buono, Marco Giuseppe MD†,‡; Damonte, Juan Ignacio MD†,§; Markley, Roshanak MD; Turlington, Jeremy MD; Kadariya, Dinesh MD; Talasaz, Azita PharmD, PhD*; Ho, Jane PharmD*; Marawan, Amr MD; Thomas, Georgia K. MD, PhD; Austin, Dana PhD; Gineste, Cyrille PhD; Gelber, Cohava PhD; Abbate, Antonio MD, PhD†,‖

Author Information
Journal of Cardiovascular Pharmacology: November 2022 - Volume 80 - Issue 5 - p 672-678
doi: 10.1097/FJC.0000000000001331

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.